BioMed Research International / 2021 / Article / Fig 2

Research Article

Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation

Figure 2

Propranolol inhibits HUVECs migration. By wound healing assay, the mobility of different concentrations (30, 60, 90, and 120 μM) of propranolol on HUVECs (a) and VEGF-induced HUVECs (b) was measured. (c) Quantitative mobility analysis. Magnification, 200x; vs. NC group; ## vs. VEGF group.
(a)
(b)
(c)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.